Research has shed light on the genomic landscape of diffuse glioma through whole genome sequencing. Studies have examined the genomic and epigenomic characteristics of various types of gliomas, including lower-grade and brainstem gliomas. The findings appear to have implications for understanding the molecular features and clinical actionability of these tumors.